US regulatory framework for lab-developed tests gets underway
This article was originally published in Clinica
Executive Summary
The US FDA followed through with its promise to officially issue its proposals to regulate laboratory-developed tests (LDTs) as soon as possible under congressional notification requirements with the posting of two draft guidances at the end of last month.